Authors:
Saylors, RL
Stine, KC
Sullivan, J
Kepner, JL
Wall, DA
Bernstein, ML
Harris, MB
Hayashi, R
Vietti, TJ
Citation: Rl. Saylors et al., Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: A pediatric oncology group phase II study, J CL ONCOL, 19(15), 2001, pp. 3463-3469
Authors:
Thomas, PRM
Deutsch, M
Kepner, JL
Boyett, JM
Krischer, J
Aronin, P
Albright, L
Allen, JC
Packer, RJ
Linggood, R
Mulhern, R
Stehbens, JA
Langston, J
Stanley, P
Duffner, P
Rorke, L
Cherlow, J
Friedman, HS
Finlay, JL
Vietti, TJ
Kun, LE
Citation: Prm. Thomas et al., Low-stage medulloblastoma: Final analysis of trial comparing standard-dosewith reduced-dose neuraxis irradiation, J CL ONCOL, 18(16), 2000, pp. 3004-3011
Authors:
Navid, F
Mosijczuk, AD
Head, DR
Borowitz, MJ
Carroll, AJ
Brandt, JM
Link, MP
Rozans, MK
Thomas, GA
Schwenn, MR
Shields, DJ
Vietti, TJ
Pullen, DJ
Citation: F. Navid et al., Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a E-precursor immunophenotype: the Pediatric Oncology Group experience, LEUKEMIA, 13(1), 1999, pp. 135-141